Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

FOXO

FOXO Technologies Inc

Dec 12 • 10:25AM ET

0.4512

Dollar change -0.0368
Percentage change -7.54	%

Healthcare • Health Information Services • USA • AMEX

Peers: ILMN EXAS QGEN TXG BGNE GH MYGN CDNA PACB TWST

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.26	Insider Own	15.44%	Shs Outstand	17.48M	Perf Week	-9.20%
Market Cap	7.89M	Forward P/E	-	EPS next Y	-	Insider Trans	-59.12%	Shs Float	14.78M	Perf Month	-52.00%
Income	-11.44M	PEG	-	EPS next Q	-	Inst Own	1.89%	Short Float	25.99%	Perf Quarter	148.73%
Sales	1.28M	P/S	6.16	EPS this Y	-	Inst Trans	10.46%	Short Ratio	0.08	Perf Half Y	88.87%
Book/sh	-1.29	P/B	-	EPS next Y	-	ROA	-41.36%	Short Interest	3.84M	Perf Year	57.49%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-1754.50%	52W Range	0.13 - 1.30	Perf YTD	41.13%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-138.42%	52W High	-65.29%	Beta	3.40
Dividend TTM	-	Quick Ratio	-	Sales past 5Y	-1111.72%	Gross Margin	-	52W Low	247.08%	ATR (14)	0.12
Dividend Ex-Date	-	Current Ratio	0.08	EPS Y/Y TTM	91.91%	Oper. Margin	-585.20%	RSI (14)	47.76	Volatility	12.43% 26.03%
Employees	5	Debt/Eq	-	Sales Y/Y TTM	-52.07%	Profit Margin	-890.81%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	79.39%	Payout	-	Rel Volume	0.01	Prev Close	0.49
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	5054.17%	Earnings	-	Avg Volume	47.84M	Price	0.45
SMA20	-16.95%	SMA50	19.38%	SMA200	58.00%	Trades		Volume	128,431	Change	-7.54%

Dec-11-24 08:00AM	FOXO TECHNOLOGIES INC. ANNOUNCES RESTRUCTURING AND CAPITAL RAISING TRANSACTIONS AND APPOINTS SEAMUS LAGAN AS CHIEF EXECUTIVE OFFICER (GlobeNewswire)
Dec-02-24 08:00AM	FOXO TECHNOLOGIES INC. ANNOUNCES RESULTS OF SPECIAL MEETING OF SHAREHOLDERS (GlobeNewswire) -11.58%
Nov-25-24 11:15AM	FOXO TECHNOLOGIES INC., CONFIRMS DETAILS OF SPECIAL MEETING OF SHAREHOLDERS ON NOVEMBER 29, 2024. (GlobeNewswire) -28.31%
08:00AM	FOXO TECHNOLOGIES INC., CONFIRMS DETAILS OF SPECIAL MEETING OF SHAREHOLDERS ON DECEMBER 29, 2024. (GlobeNewswire)
Nov-18-24 08:30AM	FOXO TECHNOLOGIES INC.'S BOARD OF DIRECTORS ANNOUNCES SPECIAL MEETING OF SHAREHOLDERS (GlobeNewswire) +6.35%
08:30AM	Loading…
Oct-15-24 08:30AM	FOXO TECHNOLOGIES INC., PROVIDES UPDATE ON 2024 ACCOMPLISHMENTS AND PLANS FOR REMAINDER OF THE YEAR (GlobeNewswire) +6.98%
Sep-17-24 09:00AM	Foxo Technologies, Inc., Completes the Acquisition of Revenue Generating Operations From Rennova Health, Inc. (GlobeNewswire) -5.32%
Aug-08-24 08:30AM	FOXO Technologies Subsidiary, Myrtle Recovery Centers, Receives Two Full Licenses from the Tennessee Department of Mental Health and Substance Abuse Services (GlobeNewswire) -9.58%
Jul-16-24 04:30PM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements (GlobeNewswire)
Jul-01-24 08:30AM	Foxo Technologies, Inc., Regains Compliance with SEC Reporting Requirements (GlobeNewswire) +6.55%
Jun-18-24 08:30AM	FOXO Technologies Inc. Secures Up to $2.8 Million in Senior Notes to Fund Previously Announced Acquisition of Myrtle Recovery Centers, Inc. and Provide Additional Working Capital (GlobeNewswire)
Jun-17-24 08:30AM	RENNOVA HEALTH, INC. ANNOUNCES STOCK EXCHANGE AGREEMENTS WITH FOXO TECHNOLOGIES, INC. FOR TWO OPERATING SUBSIDIARIES (GlobeNewswire) -10.93%
Jun-14-24 05:30PM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Completes Steps it Believes are Required to Regain Compliance (GlobeNewswire) +20.97%
08:30AM	FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc. (GlobeNewswire)
Apr-23-24 05:00PM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements (GlobeNewswire)
09:32AM	Loading…
Feb-14-24 09:32AM	FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global (GlobeNewswire) -8.50%
Jan-25-24 05:00PM	FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors (Business Wire)
Jan-22-24 08:30AM	FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions (Business Wire) -14.49%
Dec-19-23 08:30AM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements (Business Wire)
Dec-01-23 09:01AM	FOXO Technologies On Track to Commence Commercial Rollout of VITHAR AI Health Coach in Early 2024 (Business Wire) +22.82%
Nov-29-23 04:30PM	FOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q (Business Wire) -5.49%
Nov-10-23 08:30AM	FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR AI Health Coach (Business Wire)
Nov-08-23 09:00AM	FOXO Technologies to Unveil VITHAR AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time (Business Wire) -21.89%
Nov-07-23 09:23AM	FOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock Split (Business Wire) -17.53%
Oct-30-23 08:30AM	FOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Companys Epigenetic Data with the Power of AI (Business Wire) -24.80%
Oct-27-23 05:15PM	FOXO Technologies Inc. Announces Reverse Stock Split (Business Wire) -6.99%
Oct-23-23 08:00AM	FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy (Business Wire)
Oct-13-23 08:00AM	FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers (Business Wire) +8.47%
Oct-06-23 08:30AM	FOXO Technologies Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions (Business Wire) +17.20%
Sep-06-23 08:30AM	FOXO Technologies Announces Agreement With Atrio Insurance (Business Wire) +14.48%
08:30AM	Loading…
Aug-31-23 08:30AM	FOXO Technologies Inc. Announces NYSE American Acceptance of Compliance Plan (Business Wire) +7.97%
Aug-18-23 04:15PM	FOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE American (Business Wire)
Aug-17-23 08:30AM	FOXO Technologies Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity (Business Wire)
Aug-10-23 04:05PM	FOXO Technologies Announces Second Quarter 2023 Financial Results (Business Wire) -8.08%
Aug-08-23 08:30AM	FOXO Technologies Sets Second Quarter 2023 Business Update Call for Thursday, August 10, 2023 at 3:15 p.m. CT (Business Wire) -9.77%
Aug-07-23 08:30AM	Longevity Biotech Companies GERO and FOXO Technologies to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health Trajectories (Business Wire) -7.98%
Jul-19-23 08:00AM	FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis (Business Wire) +19.07%
Jun-16-23 05:30AM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements (Business Wire) -5.02%
May-30-23 05:09PM	FOXO Technologies Announces Results of Annual Stockholders Meeting (Business Wire) +14.60%
May-17-23 04:30PM	NYSE American Has Commenced Delisting Proceedings in the FOXO WS warrants of FOXO Technologies Inc. (Business Wire) -5.97%
May-11-23 04:15PM	FOXO Technologies Announces First Quarter 2023 Financial Results (Business Wire)
Apr-18-23 08:00AM	FOXO Technologies Announces Resignation of Taylor Fay, Chief Operating Officer (Business Wire) -8.08%
08:00AM	FOXO Technologies Announces Direct-to-Consumer Launch of Longevity Report Beta Product (Business Wire)
Mar-30-23 04:05PM	FOXO Technologies Announces Full Year 2022 Financial Results and Recent Business Highlights (Business Wire) +13.51%
Mar-22-23 07:00PM	FOXO Technologies Inc. Sets Fourth Quarter and Full Year 2022 Business Update Call for Thursday, March 30, 2023 at 3:15 p.m. CT (Business Wire)
Dec-08-22 04:15PM	FOXO LIFE to Begin Distribution Relationship with AmSuisse to Sell Life Insurance Designed to Keep You Alive (Business Wire)
Nov-23-22 06:30PM	FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022 (Business Wire) -13.33%
Nov-15-22 12:57PM	FOXO Technologies Announces Management Changes and Delays Filing of Form 10-Q (Business Wire) -12.85%
01:24AM	FOXO Technologies Announces Departure of Chief Product Officer, Erin Sharoni (Business Wire)
Nov-14-22 04:31PM	FOXO Technologies Postpones Third Quarter 2022 Earnings Report and Conference Call (Business Wire) +6.64%
08:00AM	FOXO Technologies Announces Agreement With Haven Life (Business Wire)
Nov-07-22 04:01PM	FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT (Business Wire)
Oct-12-22 08:00AM	FOXO Technologies Announces First Distribution Partner and Begins Product Rollout in California; Expands Executive Team With Insurance Industry Talent (Business Wire) +59.30%

FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment refers to the research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded in 2020 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Kr8 ai Inc.	10% Owner	Jul 22 '24	Sale	0.25	1,300,000	325,000	Jul 24 04:00 PM
WHITE MARK BRIAN	Interim CEO	Jul 22 '24	Sale	0.25	1,300,000	325,000	Jul 24 04:00 PM
WARD MARTIN CHRISTOPHER	Interim CFO	Jul 22 '24	Sale	0.25	1,300,000	325,000	Jul 24 04:00 PM
WARD MARTIN CHRISTOPHER	Interim CFO	Feb 06 '24	Sale	0.42	250,000	105,000	Feb 07 03:07 PM
WHITE MARK BRIAN	Interim CEO	Feb 06 '24	Sale	0.42	250,000	105,000	Feb 07 03:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FOXO

FOXO Technologies Inc

Upgrade your FINVIZ experience